Related Experiment Video
Updated: Jun 26, 2026

11:19
Novel RNA-Binding Proteins Isolation by the RaPID Methodology
Published on: September 30, 2016
Approaching the RNA ligand for RIG-I?
Martin Schlee1, Evelyn Hartmann, Christoph Coch
1Institute of Clinical Chemistry and Pharmacology, University Hospital Bonn, Bonn, Germany.
Immunological Reviews
|January 6, 2009
Summary
The retinoic acid-inducible gene I (RIG-I) sensor recognizes viral RNA, but its exact ligands remain unclear. Reviewing literature reveals inconsistencies, potentially due to in vitro transcription methods, questioning the precise RIG-I ligand identification.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Antiviral immunity relies on recognizing viral nucleic acids.
- Retinoic acid-inducible gene I (RIG-I) is a key sensor for negative-strand RNA viruses.
- Controversy exists regarding the precise RNA structures and 5'-triphosphate requirements for RIG-I activation.
Purpose of the Study:
- To critically review existing literature on RIG-I and its potential ligands.
- To identify inconsistencies and potential sources of error in RIG-I ligand studies.
- To clarify the exact nature of RIG-I recognized RNA molecules.
Main Methods:
- Comprehensive literature review of studies investigating RIG-I and its ligands.
- Analysis of proposed RIG-I ligands, including variations in RNA structure and phosphorylation.
- Evaluation of experimental methodologies, particularly in vitro transcription techniques.
Main Results:
- At least six different RNA molecules have been proposed as RIG-I ligands.
- Proposed ligands vary in RNA structure (single-stranded, double-stranded), length, and 5'-end phosphorylation.
- Significant inconsistencies and ambiguities persist regarding the definitive RIG-I ligand.
Conclusions:
- The in vitro transcription technique and lack of rigorous validation may confound RIG-I ligand identification.
- Variations in experimental systems, dose-response analyses, and controls contribute to the ambiguity.
- Further research with refined methodologies is needed to definitively identify RIG-I ligands.
Related Concept Videos
Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
